<DOC>
	<DOC>NCT02554981</DOC>
	<brief_summary>This study will evaluate the efficacy of Restasis® in participants with dry eye disease who engage in electronic visual tasking.</brief_summary>
	<brief_title>Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion: Has Eye Symptoms when using video display terminals Has a reported history of dry eye in both eyes. Exclusion: Diagnosed with eye infection or active inflammation. Has worn contact lenses within the past 7 days or anticipated use during the study. Has used any eye drops within 2 hours. Has had laserassisted in situ keratomileusis (LASIK) within 12 months. Has used Restasis® within 90 days. Has had any eye and or/lid surgeries within 6 months. Has had cataract surgery in either eye. Has current punctal occlusion or anticipate a change in punctal occlusion status at any point during the study. Is currently taking any topical ophthalmic prescriptions or overthecounter solutions, artificial tears, gels or lid scrubs that cannot be discontinued for the trial duration. Use of medication known to cause ocular drying that is not on a stable dose for at least 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>